Share price of Jubilant Food  rises  as Nifty  strengthens

A total of 35,174 shares changed hands on the counter till 01:29PM (IST).

Shares of gained 0.57 per cent to Rs 446.15 in Thursday's trade as of 01:29PM (IST). The stock hit a high price of Rs 448.4 and low of Rs 444.0 during the session.

The return on equity (ROE) for the stock stood at 17.33 per cent. Traded volume on the counter stood at 01:29PM shares and turnover at Rs 1.56 crore around that time. The stock of quoted a 52-week high price of Rs 586.35 and 52-week low prices of Rs 420.35, respectively.

The stock's Beta value, which measures its volatility in relation to the broader market, stood at 1.0.

Promotor/FII Holding
Promoters held 41.94 per cent stake in the company as of 31-Dec-2023, while foreign investors held 27.75 per cent and domestic institutional investors had 15.41 per cent.

Key Financials
The company reported consolidated sales of Rs 1382.27 crore for the quarter ended 31-Dec-2023, up 0.48 per cent from previous quarter's Rs 1375.69 crore and up 3.05 per cent from the year-ago quarter's Rs 1341.38 crore. Net profit after tax for the latest quarter stood at Rs 65.71 crore, down 18.24 per cent from the same quarter a year ago.

Technicals
The MACD signalled a bullish bias on the counter. The MACD is known for signalling trend reversals in traded securities or indices.
It is the difference between the 26-day and 12-day exponential moving averages. A nine-day exponential moving average, called the signal line, is plotted on topof the MACD to reflect "buy" or "sell" opportunities. When the MACD crosses below the signal line, it gives a bearish signal, indicating that the price of the security may see a downward movement and vice versa.

Source: Stocks-Markets-Economic Times

Останні публікації
US man sentenced to 5 years over laundering crypto stolen from Bitfinex hack
15.11.2024 - 02:00
Lenovo Q2 profit jumps 44% on AI demand boost
15.11.2024 - 02:00
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings
15.11.2024 - 02:00
Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
15.11.2024 - 02:00
US stock futures creep lower as Powell, PPI data erode rate cut bets
15.11.2024 - 02:00
Lenovo Q2 revenue jumps 24% on premium PC sales, AI push
15.11.2024 - 02:00
Hyundai Motor to name global COO Jose Munoz as CEO, report says
15.11.2024 - 02:00
Nissan shares surge after report activist investor Oasis has picked up stake
15.11.2024 - 02:00
Tesla, financials and other 'Trump trades' drew funds in Q3, filings show
15.11.2024 - 01:00
Berkshire Hathaway takes stake in Domino's Pizza, trims more Apple in Q3
15.11.2024 - 00:00
Bluesky attracts millions as users leave Musk's X after Trump win
15.11.2024 - 00:00
Citigroup facing US probe over ties to sanctioned Russian billionaire, Bloomberg reports
15.11.2024 - 00:00
FTC's Holyoak concerned AI collecting children's data
15.11.2024 - 00:00
Chinese self-driving firm Pony AI seeks up to $4.5 billion valuation in US IPO
15.11.2024 - 00:00
Applied Materials' revenue forecast signals weak spending outside AI chips
15.11.2024 - 00:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?